












Mark Yarchoan
Founder at Adventris Pharmaceuticals
Mark Yarchoan, M.D, is an Associate Professor of Medical Oncology at Johns Hopkins. Dr. Yarchoan runs an NCI-funded laboratory focused on developing novel immunotherapies, with a focus on cancer vaccines. He has led multiple international clinical trials of immunotherapy agents including neoantigen-targeted cancer vaccines. Dr. Yarchoan has received multiple honors, including the ASCO Young Investigator Award and the ASCO Career Development Award.
Follow Mark
Previously at

The Johns Hopkins University School of Medicine

Penn Medicine, University of Pennsylvania Health System
Alumnus of

University of Pennsylvania School of Medicine

Amherst College